Friday, December 18, 2015

Glaxo Buys Bristol-Myers Squibb's HIV Assets

GlaxoSmithKline has agreed to pay Bristol-Myers Squibb up to $1.5 billion to acquire the U.S. company’s pipeline of HIV drugs.

from WSJ.com: US Business http://ift.tt/1PcEvHb
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)